SBIO
Fund Stats as of 07/25/2017
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $29.23
Last Trade Price $29.24
NAV $29.21
NAV Change $-0.40
Total Net Assets $121,210,109
Total Market Value $121,224,925
Premium/Discount(%) 0.07%
Difference ($) $0.02
Volume 72,831
Shares Outstanding 4,150,000
Expenses as of 03/31/2016
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Quarterly Scorecard 
Statutory Prospectus 
Resource Library  

Index Characteristics as of 06/30/2017, subject to change

Index Top Ten Holdings

Index Name % of Index
Exelixis Inc 5.28
KITE PHARMA INC 4.66
TARO PHARMACEUTICAL IN 3.65
BLUEBIRD BIO INC 3.42
AKORN INC 3.32
GALAPAGOS NV-SPON ADR 3.09
OPKO HEALTH INC 2.92
ACADIA PHARMACEUTICALS 2.7
PORTOLA PHARMACEUTICA 2.54
NEKTAR THERAPEUTICS 2.41

PMBI Drug Development Pipeline

Pre-Clinical 315
Phase I 304
Phase II 374
Phase III 162
Regulatory Filing for Approval 47
Other 9

Index Profile

Index Description Value
Number of Companies 91
Market Capitalization ($ Agg. Millions) $128,063
Company Size ($ Millions)
   Average $2,680
   Median $800
   Largest $7,204
   Smallest $154
% Weight Largest Company 5.28%
Top 10 Holdings (% Market Cap Share) 33.99%
Correlation with S&P 500® Index 0.56